Table 2.

Overall seroprevalence of SFSV and TOSV in humans.

		SFSV	TOSV
Characteristics	Tested	n (%; 95% CI)	n (%; 95% CI)
Gender
Female	28	0 (0.0; 0.0–12.1)	0 (0.0; 0.0–12.1)
Male	990	93 (9.4; 7.7–11.4)	8 (0.8; 0.4–1.6)
Nationality⁎
Saudi	339	19 (5.6; 3.6–8.6)	0 (0.0; 0.0–1.1)
Non-Saudi	679	74 (10.9; 8.8–13.5)	8 (1.2; 0.6–2.3)
Age⁎
≤ 30	461	33 (7.2; 5.1–9.9)	3 (0.7; 0.2–1.9)
31–50	522	51 (9.8; 7.5–12.6)	4 (0.8; 0.3–2.0)
> 51	35	9 (25.7; 14.2–42.1)	1 (2.9; 0.5–14.5)
Total	1018	93 (9.1; 7.5–11.1)	8 (0.8; 0.4–1.5)

^⁎Statistically significant (p < 0.001) in SFSV but not TOSV. The cut-off value for positivity was set at titer ≥10.